首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
type 1 diabetic with cardiomyopathy相关文献:
Diabetic Cardiomyopathy.
Dillmann WH.
Circ Res. 2019 Apr 12;124(8):1160-1162. doi: 10.1161/CIRCRESAHA.118.314665.
PMID:30973809
Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53.
Tang YJ, Zhang Z, Yan T, Chen K, Xu GF, Xiong SQ, Wu DQ, Chen J, Jose PA, Zeng CY, Fu JJ.
Cardiovasc Diabetol. 2024 Apr 2;23(1):116. doi: 10.1186/s12933-024-02183-5.
PMID:38566123
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L.
Nat Rev Cardiol. 2020 Sep;17(9):585-607. doi: 10.1038/s41569-020-0339-2. Epub 2020 Feb 20.
PMID:32080423
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Jia G, DeMarco VG, Sowers JR.
Nat Rev Endocrinol. 2016 Mar;12(3):144-53. doi: 10.1038/nrendo.2015.216. Epub 2015 Dec 18.
PMID:26678809
Heart failure in diabetes.
Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, Gambardella J, Santulli G.
Metabolism. 2021 Dec;125:154910. doi: 10.1016/j.metabol.2021.154910. Epub 2021 Oct 8.
PMID:34627874
Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC, Abel ED.
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.
PMID:30605420
Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M, Li Y, Li S, Lv J.
Front Endocrinol (Lausanne). 2022 Apr 7;13:851941. doi: 10.3389/fendo.2022.851941. eCollection 2022.
PMID:35464057
Molecular mechanisms of diabetic cardiomyopathy.
Bugger H, Abel ED.
Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30.
PMID:24477973
Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy.
Lu QB, Ding Y, Liu Y, Wang ZC, Wu YJ, Niu KM, Li KX, Zhang JR, Sun HJ.
J Adv Res. 2023 Sep;51:161-179. doi: 10.1016/j.jare.2022.10.014. Epub 2022 Nov 9.
PMID:36334887
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M, Waldman M, Yadin D, Nudelman V, Shainberg A, Abraham NG, Freimark D, Kornowski R, Aravot D, Hochhauser E, Arad M.
Cardiovasc Diabetol. 2020 Jan 10;19(1):7. doi: 10.1186/s12933-019-0980-4.
PMID:31924211
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3